Clinical Trial

A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers

Name: A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers — clinical trial record (NCT07297693)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated December 22, 2025 (before its estimated March 25, 2026 completion). Its status may not reflect the trial's current state.

Summary

The purpose of this study is to evaluate the pharmacokinetic characteristics and safety between HIP2503 and HCP1306 in healthy volunteers.

Trial Details

NCT Number	NCT07297693
Lead Sponsor	Hanmi Pharmaceutical Company Limited
Conditions	Healthy
Enrollment	60 participants
Start Date	2025-12-19
Primary Completion	2026-03-25 (estimated)
Study Completion	2026-04-10 (estimated)
Updated on ClinicalTrials.gov	2025-12-22